Henry Schein opens the week with robust sector positioning, shares trade steadily on Nasdaq
26.06.2026 - 16:10:58 | ad-hoc-news.de
By Julia Schmitt, Sector & Peer Group desk. Reviewed prior to publication on 2026-06-26, 16:10.
Henry Schein (US42548G1040) enters the new trading week as a mid-cap distributor in the U.S. health care segment, with its shares listed on Nasdaq under the ticker HSIC. The company’s recent earnings and sector data frame its current positioning among medical suppliers, with peers such as Siemens Healthineers and Hensoldt active in adjacent European health technology and defense-linked niches.
What recent earnings show
Henry Schein reported first-quarter 2026 earnings on May 5, 2026, posting adjusted EPS of 1.32 dollars, beating the consensus estimate of 1.20 dollars according to MarketBeat. The beat of 0.12 dollars per share underscores a stable profit picture in its dental and medical distribution businesses, which span the United States and international markets.
Zacks notes that before the Q1 release Henry Schein had exceeded earnings expectations in three of the previous four quarters, with an average surprise of 2.14 percent, illustrating consistent execution relative to analyst forecasts. Ahead of those Q1 numbers, Zacks assigned the stock a Rank 3 rating, indicating a hold stance within its coverage universe.
Analyst views and sector context
On MarketBeat, Henry Schein is classified within the medical sector and the MED/DENTAL - SUPP sub-industry, reflecting its focus on supplying dental and medical practices rather than manufacturing major imaging hardware. The shares closed at 83.69 dollars on Nasdaq on June 25, 2026, up 0.87 dollars or 1.05 percent for that session, with extended trading indications of 82.52 dollars in early electronic trade. This level sits near the top end of a recent 50-day price range cited by MarketBeat, which runs from roughly 68.99 to 83.69 dollars.
Zacks highlights Henry Schein’s Earnings ESP of plus 0.28 percent ahead of the May 5, 2026 release, a metric it uses to gauge potential positive surprises based on the most recent analyst revisions compared with its consensus. Together with the prior track record of beating estimates, this data point contributed to expectations of modest upside versus forecasts in the Q1 report.
More background and price data on the Henry Schein shares
Further news, price moves and analyst commentary on Henry Schein can be found in the dedicated topic section and on the company’s own investor pages.
How Henry Schein earns its money
Henry Schein generates revenue primarily by distributing dental and medical supplies, equipment and related services to practices and clinics, as reflected in its MED/DENTAL - SUPP industry classification on MarketBeat. The portfolio includes consumables for dental offices, small equipment for treatment rooms and software solutions for practice management, all positioned to support recurring demand from health professionals.
Where the shares trade today
The Henry Schein shares (US42548G1040) trade on Nasdaq under the symbol HSIC at 83.69 dollars as of 2026-06-25, 16:00 Eastern, based on MarketBeat’s latest closing data. In extended electronic trading, the quote of 82.52 dollars at 06:43 Eastern on June 26, 2026 gives an early indication of investor sentiment ahead of the regular session.
Key data on the Henry Schein shares
- Company: Henry Schein, Inc.
- ISIN: US42548G1040
- WKN: 897961
- Ticker: HSIC
- Trading venue: NASDAQ
- Price (as of 2026-06-25, 16:00): 83.69 USD
- Market cap: 10.0 billion USD (as of 2026-06-25, based on Nasdaq-level data and MarketBeat sector figures)
- Sector / industry: Medical sector, MED/DENTAL - SUPP sub-industry
- Index membership: Member of the broader U.S. medical sector universe alongside distributors and health technology names, without inclusion in headline indices such as the S&P 500 per current public listings.
- Next earnings date: Not officially scheduled beyond the May 5, 2026 Q1 report per recent MarketBeat and Zacks disclosures.
Disclaimer: This text is for informational purposes only and does not constitute investment advice, a recommendation to buy or sell securities, or a solicitation of any transaction. Figures and data are based on sources cited and may change over time.
